These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 799566)

  • 21. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 23. Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Prichard BN; Thompson FO; Boakes AJ; Joekes AM
    Clin Sci Mol Med Suppl; 1975 Jun; 2():97s-100s. PubMed ID: 802650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of bethanidine sulfate in the treatment of arterial hypertension].
    Cristodorescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(4):279-89. PubMed ID: 778
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol.
    Fernandez PG; Snedden W; Kim BK; Lee CC
    Can J Physiol Pharmacol; 1985 Apr; 63(4):304-8. PubMed ID: 3159468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sotalol and bethanidine-an open general practice study in the combination therapy of hypertension.
    Rowlands G; McConachie NA; Currie WJ
    Br J Clin Pract; 1977 May; 31(5):57-9. PubMed ID: 884041
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of age and the level of arterial blood pressure on the changes in forearm blood flow resulting from sudden alterations in local vascular transmural pressure.
    Fentem PH; Yates JM
    Cardiovasc Res; 1975 Jan; 9(1):56-64. PubMed ID: 1122511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of guanoclor and methyldopa in the treatment of severe hypertension.
    Mackinnon J; el-Baz LM
    Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159
    [No Abstract]   [Full Text] [Related]  

  • 32. Antagonism of bethanidine by mazindol.
    Boakes AJ
    Br J Clin Pharmacol; 1977 Aug; 4(4):486-7. PubMed ID: 901743
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency.
    Lowenstein I; Alterman L; Zelen R; Bank DE; Bank N
    J Clin Pharmacol; 1984 Oct; 24(10):436-45. PubMed ID: 6392352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs in the management of hypertension. Part II.
    Page LB; Yager HM; Sidd JJ
    Am Heart J; 1976 Jul; 92(1):114-8. PubMed ID: 961569
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlled trial of propranolol in hypertension.
    Zacharias FJ; Cowen KJ
    Br Med J; 1970 Feb; 1(5694):471-4. PubMed ID: 4907811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methyldopa on prolactin and growth hormone.
    Steiner J; Cassar J; Mashiter K; Dawes I; Fraser TR; Breckenridge A
    Br Med J; 1976 May; 1(6019):1186-8. PubMed ID: 1268617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.